Cited by 69Thyroid Disorders and TreatmentsAdrenal Hormones and DisordersGrowth Hormone and Insulin-like Growth Factors

The hypothalamic-pituitary-thyroid axis in critical illness

Fliers, E., Alkemade, A., Wiersinga, W.M.·2001·Best Practice & Research Clinical Endocrinology & Metabolism

Abstract

In severe illness, profound changes occur in the hypothalamic-pituitary-thyroid axis. The observed decrease in serum concentration of both thyroid hormones and thyrotropin (TSH) are not compatible with a negative feedback loop and suggest a major change in setpoint regulation of the hypothalamic-pituitary-thyroid axis. This is supported by post mortem studies showing a decreased expression of thyrotropin-releasing hormone in the hypothalamic paraventricular nucleus of patients with a decreased serum T3 level. In critical illness, serum T3 may even become undetectable without giving rise to an elevated concentration of serum TSH. It is currently not clearly established whether this reflects an adaptation of the organism to illness or instead a potentially harmful condition leading to hypothyroidism at tissue level. There is thus a need for randomized clinical trials in critically ill patients to investigate whether they may benefit from a normalization of thyroid hormone concentration. Recent clinical studies in these patients involving the administration of hypothalamic peptides open up new ways of achieving this.

Integrity signals

Registry

Crossref · 10.1053/beem.2001.0163

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Serum TSH may be relatively low in critically ill patients with concomitant hypothyroidism as a result of a variety of drugs, for example dopamine which inhibits TSH release.

    “As a potential complicating factor, serum TSH may be relatively low in critically ill patients with concomitant hypothyroidism as a result of a variety of drugs, for example dopamine which inhibits TSH release (for review see Fliers et al. [81]).”

    From An update on non-thyroidal illness syndrome (2021) · cites this paper as [81]

  • While serum T3 levels may decline by 30% and remain within the normal range, tissue T3 may decline by 70-80%, resulting in profound cellular hypothyroidism with normal serum TSH, FT4, and FT3 levels.

    “While serum T3 levels may decline by 30%, which is significant, but still within the so-called “normal range”, tissue T3 may decline by 70–80%, resulting in profound cellular hypothyroidism with normal serum TSH, FT4, and FT3 levels”
  • TSH may be a poor indicator of peripheral thyroid levels in conditions such as chronic stress, chronic illness, diabetes, insulin resistance, obesity, leptin resistance, depression, chronic fatigue syndrome, fibromyalgia, premenstrual syndrome, and dieting or weight gain.

    “As a result, TSH may be a poor indicator of peripheral thyroid levels in the presence of such conditions.”

Cites

Flagged first, then by citations

1 of the 43 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Fliers, E., Alkemade, A., & Wiersinga, W. M.
Affiliations
Amsterdam UMC Location University of Amsterdam (NL)
Venue
Best Practice & Research Clinical Endocrinology & Metabolism
Publisher
Elsevier BV
Published
2001-12
Volume
15
Issue
4
Pages
453-464
ISSN
1521-690X (ISSN-L)
OpenAlex
W2156519573
Cited by
69
References
43
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2020: 3 · 2019: 2 · 2017: 4 · 2016: 4 · 2015: 1 · 2014: 4 · 2013: 4 · 2012: 5
FWCI
0.19
Type
journal article
Language
en
Open access
closed
Locations
  • Best Practice & Research Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
hypothalamic-pituitary-thyroid axis, critical illness, thyroid-stimulating hormone, thyroid hormones, T3, negative feedback loop, paraventricular nucleus, thyrotropin-releasing hormone, hypothyroidism, hypothalamic neuropeptides, thyroid hormone replacement
MeSH terms
Humans, Hypothalamo-Hypophyseal System, Neuropeptides, Thyroid Diseases, Thyroid Gland, Thyroid Hormones, Critical Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review